Sirtris Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$720M
Sirtris Pharmaceuticals General Information
Description
Developer of proprietary, orally administrable, small molecule biopharmaceutical drugs intended to cure type 2 diabetes, cancer, and other diseases. The company specializes in resveratrol formulations and derivatives as activators of the SIRT1 enzyme that help in reducing heart diseases, thereby enabling patients to have access to quality medication.
Contact Information
Corporate Office
- 790 Memorial Drive
- Cambridge, MA 02139
- United States
Corporate Office
- 790 Memorial Drive
- Cambridge, MA 02139
- United States
Sirtris Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Merger/Acquisition | 05-Jun-2008 | $720M | Completed | Generating Revenue | ||
| 7. IPO | 23-May-2007 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C1) | 06-Feb-2007 | Completed | Generating Revenue | |||
| 5. Debt - General | 19-Apr-2006 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 04-Apr-2006 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 08-Mar-2005 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 01-Dec-2004 | $13M | $18M | Completed | Product Development | |
| 1. Early Stage VC (Series A) | 09-Sep-2004 | $5M | $5M | Completed | Product Development |
Sirtris Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C1 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A1 | 21,666,667 | $0.001000 | $0.6 | $0.6 | 1x | $0.6 | 19.73% | |
| Series A | 10,000,000 | $0.001000 | $0.5 | $0.5 | 1x | $0.5 | 9.1% |
Sirtris Pharmaceuticals Patents
Sirtris Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2768833-A1 | Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators | Inactive | 20-Oct-2011 | ||
| EP-2768833-A4 | Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators | Inactive | 20-Oct-2011 | ||
| WO-2013059587-A1 | Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators | Inactive | 20-Oct-2011 | ||
| WO-2013059589-A1 | Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators | Inactive | 20-Oct-2011 | ||
| WO-2013059594-A1 | Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators | Inactive | 20-Oct-2011 | C07D487/04 |
Sirtris Pharmaceuticals Signals
Sirtris Pharmaceuticals Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bessemer Venture Partners | Venture Capital | Minority | ||
| Bock Family Ventures | Venture Capital | Minority | ||
| Cardinal Partners | Venture Capital | Minority | ||
| Cycad Group | Venture Capital | Minority | ||
| Hercules Capital (San Mateo) | Lender/Debt Provider | Minority |
Sirtris Pharmaceuticals FAQs
-
When was Sirtris Pharmaceuticals founded?
Sirtris Pharmaceuticals was founded in 2004.
-
Where is Sirtris Pharmaceuticals headquartered?
Sirtris Pharmaceuticals is headquartered in Cambridge, MA.
-
What is the size of Sirtris Pharmaceuticals?
Sirtris Pharmaceuticals has 10 total employees.
-
What industry is Sirtris Pharmaceuticals in?
Sirtris Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Sirtris Pharmaceuticals a private or public company?
Sirtris Pharmaceuticals is a Private company.
-
What is the current valuation of Sirtris Pharmaceuticals?
The current valuation of Sirtris Pharmaceuticals is .
-
What is Sirtris Pharmaceuticals’s current revenue?
The current revenue for Sirtris Pharmaceuticals is .
-
How much funding has Sirtris Pharmaceuticals raised over time?
Sirtris Pharmaceuticals has raised $181M.
-
Who are Sirtris Pharmaceuticals’s investors?
Bessemer Venture Partners, Bock Family Ventures, Cardinal Partners, Cycad Group, and Hercules Capital (San Mateo) are 5 of 14 investors who have invested in Sirtris Pharmaceuticals.
-
When was Sirtris Pharmaceuticals acquired?
Sirtris Pharmaceuticals was acquired on 05-Jun-2008.
-
Who acquired Sirtris Pharmaceuticals?
Sirtris Pharmaceuticals was acquired by GSK.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process